Ultragenyx Pharmaceutical Inc. <RARE.O>: Leerink Partners cuts target price to $33 from $60
RARE•Related News
Campbell down after forecasting annual sales below estimates
CPB•
Autonomous trucking software firm PlusAI to go public in $800 million SPAC deal
TVA•
QumulusAI completes early deployment of 616 Nvidia GPUs under Runpod reserved-capacity deals
NVDA•
Kustom Entertainment details integration roadmap for pending Tickets For Less acquisition
KUST•
SoFi partners with Payward to link banking rails with digital asset markets
SOFI•